Why the study?
Does dextran 70 compared to low dose heparin combined with dihydroergotamine prevent thromboembolism in patients undergoing total hip replacement?
Does dextran 70 compared to low dose heparin combined with dihydroergotamine prevent thromboembolism in patients undergoing total hip replacement?
In patients undergoing total hip replacement, thromboembolic prophylaxis with dextran 70 or low dose heparin combined with dihydroergotamine showed no significant difference in the incidence of DVT or PE.
Answers are grounded in this paper and cite their sources.
Both regimens yield ~51% thromboembolism rates without difference; challenges adequacy of either for hip replacement and extends call for superior prophylaxis.
A prospective study of antithrombin III, determined by electroimmunochemical assay or an amidolytical method, was carried out with special reference to thromboembolism after total hip replacement. Two hundred and seven patients were randomly allocated to thromboembolic prophylaxis with dextran 70 or low dose heparin combined with dihydroergotamine. Deep vein thrombosis determined by phlebography of the operated leg or pulmonary embolism diagnosed with perfusion/ventilation scintigraphy developed in 51% of the total material and did not differ significantly between the two groups of prophylaxis or between patients with a preoperative At III below normal and those with a normal value. The correlation between the two assay methods for At III was 0.61. An initial, postoperative decrease in At III was noted with a parallel fall in hematocrit and fibrinogen, later followed by an increase of the plasma proteins. It is concluded that the immediate postoperative decrease of At III is mostly due to hemodilution.
No takes yet. Share an insight, caveat, or question.
Fredin et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: